{"transactions":[{"id":779914,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-14T21:00:37.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier."}],"balance_after":234,"derivative":{"underlying":"Common Stock","underlying_shares":234},"source":{"system":"sec-edgar","filing":"0000874716-26-000103","document":"wk-form4_1778792434.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471626000103/wk-form4_1778792434.xml","form_type":"4"}},{"id":779913,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2026-05-14T21:00:37.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier."}],"balance_after":525,"derivative":{"exercise_price":533.92,"expiration_date":"2036-05-11","underlying":"Common Stock","underlying_shares":525},"source":{"system":"sec-edgar","filing":"0000874716-26-000103","document":"wk-form4_1778792434.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471626000103/wk-form4_1778792434.xml","form_type":"4"}},{"id":785666,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-11T21:10:37.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":257,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":257},"source":{"system":"sec-edgar","filing":"0000874716-26-000084","document":"wk-form4_1778533834.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471626000084/wk-form4_1778533834.xml","form_type":"4"}},{"id":785665,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-11T21:10:37.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":257,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3561,"source":{"system":"sec-edgar","filing":"0000874716-26-000084","document":"wk-form4_1778533834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471626000084/wk-form4_1778533834.xml","form_type":"4"}},{"id":1150000,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2025-05-14T21:00:15.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":false,"shares":1279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event was earlier."}],"balance_after":0,"derivative":{"exercise_price":283.59,"expiration_date":"2030-05-05","underlying":"Common Stock","underlying_shares":1279},"source":{"system":"sec-edgar","filing":"0000874716-25-000090","document":"wk-form4_1747256407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000090/wk-form4_1747256407.xml","form_type":"4"}},{"id":1149999,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2025-05-14T21:00:15.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":false,"shares":1404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2020 annual meeting of shareholders, whichever event was earlier."}],"balance_after":0,"derivative":{"exercise_price":245.79,"expiration_date":"2029-05-07","underlying":"Common Stock","underlying_shares":1404},"source":{"system":"sec-edgar","filing":"0000874716-25-000090","document":"wk-form4_1747256407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000090/wk-form4_1747256407.xml","form_type":"4"}},{"id":1149998,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-14T21:00:15.000Z","date":"2025-05-13","kind":"sale","planned":false,"acquired":false,"shares":2683,"price":506.4097,"value":1358697.2251,"ownership":{"direct":true},"balance_after":3304,"source":{"system":"sec-edgar","filing":"0000874716-25-000090","document":"wk-form4_1747256407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000090/wk-form4_1747256407.xml","form_type":"4"}},{"id":1149997,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-14T21:00:15.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":true,"shares":1279,"price":283.59,"value":362711.61,"ownership":{"direct":true},"balance_after":5987,"source":{"system":"sec-edgar","filing":"0000874716-25-000090","document":"wk-form4_1747256407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000090/wk-form4_1747256407.xml","form_type":"4"}},{"id":1149996,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-14T21:00:15.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":true,"shares":1404,"price":245.79,"value":345089.16,"ownership":{"direct":true},"balance_after":4708,"source":{"system":"sec-edgar","filing":"0000874716-25-000090","document":"wk-form4_1747256407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000090/wk-form4_1747256407.xml","form_type":"4"}},{"id":1155525,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-08T23:01:05.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2026 annual meeting of shareholders, whichever event earlier."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2026 annual meeting of shareholders, whichever event earlier."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2026 annual meeting of shareholders, whichever event earlier."}],"balance_after":257,"derivative":{"underlying":"Common Stock","underlying_shares":257},"source":{"system":"sec-edgar","filing":"0000874716-25-000079","document":"wk-form4_1746745258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000079/wk-form4_1746745258.xml","form_type":"4"}},{"id":1155524,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2025-05-08T23:01:05.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2026 annual meeting of shareholders, whichever event is earlier."}],"balance_after":600,"derivative":{"exercise_price":486.61,"expiration_date":"2035-05-06","underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0000874716-25-000079","document":"wk-form4_1746745258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000079/wk-form4_1746745258.xml","form_type":"4"}},{"id":1155523,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-08T23:01:05.000Z","date":"2025-05-06","kind":"exercise","planned":false,"acquired":false,"shares":262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event was earlier."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event was earlier."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event was earlier."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":262},"source":{"system":"sec-edgar","filing":"0000874716-25-000079","document":"wk-form4_1746745258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000079/wk-form4_1746745258.xml","form_type":"4"}},{"id":1155522,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-08T23:01:05.000Z","date":"2025-05-06","kind":"exercise","planned":false,"acquired":true,"shares":262,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3304,"source":{"system":"sec-edgar","filing":"0000874716-25-000079","document":"wk-form4_1746745258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000079/wk-form4_1746745258.xml","form_type":"4"}},{"id":1523836,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-05-08T23:01:56.000Z","date":"2024-05-06","kind":"grant","planned":false,"acquired":true,"shares":262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vest in in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event is earlier."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vest in in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event is earlier."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vest in in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event is earlier."}],"balance_after":262,"derivative":{"underlying":"Common Stock","underlying_shares":262},"source":{"system":"sec-edgar","filing":"0000874716-24-000101","document":"wk-form4_1715209304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000101/wk-form4_1715209304.xml","form_type":"4"}},{"id":1523835,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2024-05-08T23:01:56.000Z","date":"2024-05-06","kind":"grant","planned":false,"acquired":true,"shares":609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event is earlier."}],"balance_after":609,"derivative":{"exercise_price":476.87,"expiration_date":"2034-05-05","underlying":"Common Stock","underlying_shares":609},"source":{"system":"sec-edgar","filing":"0000874716-24-000101","document":"wk-form4_1715209304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000101/wk-form4_1715209304.xml","form_type":"4"}},{"id":1532280,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-01T20:24:33.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 1, 2025, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.62,"expiration_date":"2034-04-30","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-011860","document":"form4-05012024_080522.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094159/000141588924011860/form4-05012024_080522.xml","form_type":"4"}},{"id":1554552,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-02T20:05:38.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":5209,"price":3,"value":15627.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares will be issued to the reporting person pursuant to the issuer's non-employee director compensation policy in lieu of board and committee retainer fees of $15,625."}],"balance_after":98459,"source":{"system":"sec-edgar","filing":"0001415889-24-009745","document":"form4-04022024_040420.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094159/000141588924009745/form4-04022024_040420.xml","form_type":"4"}},{"id":1664368,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-01T22:00:18.000Z","date":"2024-01-30","kind":"grant","planned":false,"acquired":true,"shares":14,"price":521.03,"value":7294.42,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($7,500.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock as soon as practicable following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":3042,"source":{"system":"sec-edgar","filing":"0000874716-24-000009","document":"wk-form4_1706824803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000009/wk-form4_1706824803.xml","form_type":"4"}},{"id":1752685,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-01T22:06:11.000Z","date":"2023-10-30","kind":"grant","planned":false,"acquired":true,"shares":19,"price":396.39,"value":7531.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($7,500.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock as soon as practicable following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":3028,"source":{"system":"sec-edgar","filing":"0000874716-23-000129","document":"wk-form4_1698876362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000129/wk-form4_1698876362.xml","form_type":"4"}},{"id":1819717,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-01T21:19:55.000Z","date":"2023-07-28","kind":"grant","planned":false,"acquired":true,"shares":14,"price":552.78,"value":7738.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($7,500.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock as soon as practicable following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":3009,"source":{"system":"sec-edgar","filing":"0000874716-23-000101","document":"wk-form4_1690924784.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000101/wk-form4_1690924784.xml","form_type":"4"}},{"id":1883175,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-22T20:25:32.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 19, 2024, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":1.98,"expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-23-031462","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094159/000120919123031462/doc4.xml","form_type":"4"}},{"id":1885868,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2023-05-19T21:02:50.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":257,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors."}],"balance_after":601,"derivative":{"underlying":"Common Stock","underlying_shares":257},"source":{"system":"sec-edgar","filing":"0000874716-23-000079","document":"wf-form4_168453013579667.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000079/wf-form4_168453013579667.xml","form_type":"4"}},{"id":1885867,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2023-05-19T21:02:50.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event is earlier."}],"balance_after":645,"derivative":{"exercise_price":487.12,"expiration_date":"2033-05-16","underlying":"Common Stock","underlying_shares":645},"source":{"system":"sec-edgar","filing":"0000874716-23-000079","document":"wf-form4_168453013579667.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000079/wf-form4_168453013579667.xml","form_type":"4"}},{"id":1897161,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-11T21:08:30.000Z","date":"2023-05-10","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":1.56,"value":46800.0,"ownership":{"direct":true},"balance_after":93250,"source":{"system":"sec-edgar","filing":"0001209191-23-028816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094159/000120919123028816/doc4.xml","form_type":"4"}},{"id":1909166,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-02T22:01:54.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":13,"price":492.16,"value":6398.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($6,562.50) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock as soon as practicable following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2995,"source":{"system":"sec-edgar","filing":"0000874716-23-000035","document":"wf-form4_168306488969915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000035/wf-form4_168306488969915.xml","form_type":"4"}},{"id":2009306,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2023-02-17T22:06:03.000Z","date":"2023-02-16","kind":"exercise","acquired":false,"shares":2187,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 8, 2019, the date of the 2019 annual meeting of shareholders."}],"balance_after":0,"derivative":{"exercise_price":206.62,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":2187},"source":{"system":"sec-edgar","filing":"0001567619-23-003312","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923003312/doc1.xml","form_type":"4"}},{"id":2009305,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-17T22:06:03.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":2187,"price":511.6797,"value":1119043.5039,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average price of the shares sold ranging from a low of $511.65 to a high of $512.29 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":2982,"source":{"system":"sec-edgar","filing":"0001567619-23-003312","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923003312/doc1.xml","form_type":"4"}},{"id":2009304,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-17T22:06:03.000Z","date":"2023-02-16","kind":"exercise","acquired":true,"shares":2187,"price":206.62,"value":451877.94,"ownership":{"direct":true},"balance_after":5169,"source":{"system":"sec-edgar","filing":"0001567619-23-003312","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923003312/doc1.xml","form_type":"4"}},{"id":2039191,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-01T22:00:16.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":14,"price":482.95,"value":6761.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($6,562.50) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock as soon as practicable following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2982,"source":{"system":"sec-edgar","filing":"0001567619-23-001663","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923001663/doc1.xml","form_type":"4"}},{"id":2093870,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2022-12-07T21:30:49.000Z","date":"2022-12-05","kind":"exercise","acquired":false,"shares":3046,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of option to buy 3,046 shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2018 annual meeting of shareholders, whichever event was earlier."}],"balance_after":0,"derivative":{"exercise_price":160.28,"expiration_date":"2027-05-02","underlying":"Common Stock","underlying_shares":3046},"source":{"system":"sec-edgar","filing":"0001567619-22-021390","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922021390/doc1.xml","form_type":"4"}},{"id":2093869,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-07T21:30:49.000Z","date":"2022-12-05","kind":"sale","acquired":false,"shares":3046,"price":424.91,"value":1294275.86,"ownership":{"direct":true},"balance_after":2968,"source":{"system":"sec-edgar","filing":"0001567619-22-021390","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922021390/doc1.xml","form_type":"4"}},{"id":2093868,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-07T21:30:49.000Z","date":"2022-12-05","kind":"exercise","acquired":true,"shares":3046,"price":160.28,"value":488212.88,"ownership":{"direct":true},"balance_after":6014,"source":{"system":"sec-edgar","filing":"0001567619-22-021390","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922021390/doc1.xml","form_type":"4"}},{"id":2110842,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-18T21:01:46.000Z","date":"2022-11-17","kind":"purchase","acquired":true,"shares":20000,"price":1.87,"value":37400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.855 to $1.89 per share, with a weighted average purchase price of $1.87 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":63250,"source":{"system":"sec-edgar","filing":"0001209191-22-057823","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094159/000120919122057823/doc4.xml","form_type":"4"}},{"id":2128904,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-01T21:00:20.000Z","date":"2022-10-28","kind":"grant","acquired":true,"shares":18,"price":364.28,"value":6557.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($6,562.50) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock as soon as practicable following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2968,"source":{"system":"sec-edgar","filing":"0001567619-22-019020","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922019020/doc1.xml","form_type":"4"}},{"id":2198274,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T21:00:34.000Z","date":"2022-07-29","kind":"grant","acquired":true,"shares":16,"price":399.18,"value":6386.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($6,562.50) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock as soon as practicable following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2950,"source":{"system":"sec-edgar","filing":"0001567619-22-014808","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922014808/doc1.xml","form_type":"4"}},{"id":2262418,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T20:13:48.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 18, 2023, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":21000,"derivative":{"exercise_price":0.6,"expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-22-030991","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094159/000120919122030991/doc4.xml","form_type":"4"}},{"id":2272698,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2022-05-13T21:42:19.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":945,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of shareholders, whichever event is earlier."}],"balance_after":945,"derivative":{"exercise_price":333.9,"expiration_date":"2032-05-10","underlying":"Common Stock","underlying_shares":945},"source":{"system":"sec-edgar","filing":"0001567619-22-010573","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922010573/doc1.xml","form_type":"4"}},{"id":2272697,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2022-05-13T21:42:19.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":344,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors."}],"balance_after":344,"derivative":{"underlying":"Common Stock","underlying_shares":344},"source":{"system":"sec-edgar","filing":"0001567619-22-010573","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922010573/doc1.xml","form_type":"4"}},{"id":2285267,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-03T21:01:10.000Z","date":"2022-04-29","kind":"grant","acquired":true,"shares":15,"price":430.48,"value":6457.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($6,562.50) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock as soon as practicable following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2934,"source":{"system":"sec-edgar","filing":"0001567619-22-009426","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922009426/doc1.xml","form_type":"4"}},{"id":2419999,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-01T22:03:06.000Z","date":"2022-01-28","kind":"grant","acquired":true,"shares":13,"price":489.05,"value":6357.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($6,562.50) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2919,"source":{"system":"sec-edgar","filing":"0001567619-22-002287","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922002287/doc1.xml","form_type":"4"}},{"id":2529843,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-02T21:01:38.000Z","date":"2021-10-29","kind":"grant","acquired":true,"shares":10,"price":666.14,"value":6661.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($6,562.50) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2906,"source":{"system":"sec-edgar","filing":"0001567619-21-019216","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921019216/doc1.xml","form_type":"4"}},{"id":2606028,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2021-08-12T21:01:12.000Z","date":"2021-08-10","kind":"exercise","acquired":false,"shares":2402,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the date of the 2017 annual meeting of shareholders."}],"balance_after":0,"derivative":{"exercise_price":85,"expiration_date":"2026-05-03","underlying":"Common Stock","underlying_shares":2402},"source":{"system":"sec-edgar","filing":"0001567619-21-015281","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921015281/doc1.xml","form_type":"4"}},{"id":2606027,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-12T21:01:12.000Z","date":"2021-08-10","kind":"sale","acquired":false,"shares":2402,"price":679.5818,"value":1632355.4836,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average price of the shares sold ranging from a low of $679.47 to a high of $680.09 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":2896,"source":{"system":"sec-edgar","filing":"0001567619-21-015281","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921015281/doc1.xml","form_type":"4"}},{"id":2606026,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-12T21:01:12.000Z","date":"2021-08-10","kind":"exercise","acquired":true,"shares":2402,"price":85,"value":204170.0,"ownership":{"direct":true},"balance_after":5298,"source":{"system":"sec-edgar","filing":"0001567619-21-015281","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921015281/doc1.xml","form_type":"4"}},{"id":2618897,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-03T21:02:03.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":10,"price":678.53,"value":6785.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1.\tRepresents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($6,562.50) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2896,"source":{"system":"sec-edgar","filing":"0001567619-21-014356","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921014356/doc1.xml","form_type":"4"}},{"id":2693983,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-28T00:58:08.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest on May 18, 2022, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":10500,"derivative":{"exercise_price":2.55,"expiration_date":"2031-05-17","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-21-036384","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1094159/000120919121036384/doc4.xml","form_type":"4"}},{"id":2693982,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T00:58:08.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The security represents restricted stock units granted to the reporting person. Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares underlying these restricted stock units vest on May 18, 2022, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":43250,"source":{"system":"sec-edgar","filing":"0001209191-21-036384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094159/000120919121036384/doc4.xml","form_type":"4"}},{"id":2699835,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2021-05-24T22:15:53.000Z","date":"2021-05-21","kind":"exercise","acquired":false,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the date of the 2017 annual meeting of shareholders."}],"balance_after":2402,"derivative":{"exercise_price":85,"expiration_date":"2026-05-03","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-21-011069","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921011069/doc1.xml","form_type":"4"}},{"id":2699834,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T22:15:53.000Z","date":"2021-05-21","kind":"sale","acquired":false,"shares":2500,"price":539.5673,"value":1348918.25,"ownership":{"direct":true},"balance_after":2886,"source":{"system":"sec-edgar","filing":"0001567619-21-011069","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921011069/doc1.xml","form_type":"4"}},{"id":2699833,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T22:15:53.000Z","date":"2021-05-21","kind":"exercise","acquired":true,"shares":2500,"price":85,"value":212500.0,"ownership":{"direct":true},"balance_after":5386,"source":{"system":"sec-edgar","filing":"0001567619-21-011069","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921011069/doc1.xml","form_type":"4"}},{"id":2713332,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2021-05-14T22:02:21.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":723,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2022 annual meeting of shareholders, whichever event is earlier."}],"balance_after":723,"derivative":{"exercise_price":512.31,"expiration_date":"2031-05-11","underlying":"Common Stock","underlying_shares":723},"source":{"system":"sec-edgar","filing":"0001567619-21-010254","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921010254/doc1.xml","form_type":"4"}},{"id":2713331,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2021-05-14T22:02:21.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":224,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2022 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2022 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2022 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."}],"balance_after":3387,"derivative":{"underlying":"Common Stock","underlying_shares":224},"source":{"system":"sec-edgar","filing":"0001567619-21-010254","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921010254/doc1.xml","form_type":"4"}},{"id":2731435,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-04T23:01:20.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":11,"price":548.99,"value":6038.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($6,250.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2886,"source":{"system":"sec-edgar","filing":"0001567619-21-009017","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921009017/doc1.xml","form_type":"4"}},{"id":2837133,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2021-02-24T22:00:23.000Z","date":"2021-02-22","kind":"exercise","acquired":false,"shares":1000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the date of the 2017 annual meeting of shareholders."}],"balance_after":4902,"derivative":{"exercise_price":85,"expiration_date":"2026-05-03","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001567619-21-004793","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004793/doc1.xml","form_type":"4"}},{"id":2837132,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Incentive Stock Option (right-to-buy)","published_at":"2021-02-24T22:00:23.000Z","date":"2021-02-22","kind":"exercise","acquired":false,"shares":898,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 449 shares on May 6, 2015, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the \"Stock Split\").  The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split."}],"balance_after":0,"derivative":{"exercise_price":79.54,"expiration_date":"2025-02-13","underlying":"Common Stock","underlying_shares":898},"source":{"system":"sec-edgar","filing":"0001567619-21-004793","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004793/doc1.xml","form_type":"4"}},{"id":2837131,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-24T22:00:23.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":1888,"price":538.5673,"value":1016815.0624,"ownership":{"direct":true},"balance_after":2875,"source":{"system":"sec-edgar","filing":"0001567619-21-004793","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004793/doc1.xml","form_type":"4"}},{"id":2837130,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-24T22:00:23.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":10,"price":539.19,"value":5391.9,"ownership":{"direct":true},"balance_after":4763,"source":{"system":"sec-edgar","filing":"0001567619-21-004793","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004793/doc1.xml","form_type":"4"}},{"id":2837129,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-24T22:00:23.000Z","date":"2021-02-22","kind":"exercise","acquired":true,"shares":1000,"price":85,"value":85000.0,"ownership":{"direct":true},"balance_after":4773,"source":{"system":"sec-edgar","filing":"0001567619-21-004793","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004793/doc1.xml","form_type":"4"}},{"id":2837128,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-24T22:00:23.000Z","date":"2021-02-22","kind":"exercise","acquired":true,"shares":898,"price":79.54,"value":71426.92,"ownership":{"direct":true},"balance_after":3773,"source":{"system":"sec-edgar","filing":"0001567619-21-004793","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004793/doc1.xml","form_type":"4"}},{"id":2883374,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-03T22:01:43.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":13,"price":478.68,"value":6222.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($6,250.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2875,"source":{"system":"sec-edgar","filing":"0001567619-21-002133","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921002133/doc1.xml","form_type":"4"}},{"id":2996869,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-02T22:01:57.000Z","date":"2020-10-30","kind":"grant","acquired":true,"shares":15,"price":424.82,"value":6372.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1.\tRepresents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($6,250.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2862,"source":{"system":"sec-edgar","filing":"0001567619-20-018549","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920018549/doc1.xml","form_type":"4"}},{"id":3050380,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2020-08-21T21:00:22.000Z","date":"2020-08-20","kind":"exercise","acquired":false,"shares":3722,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 3,861 shares on May 6, 2016, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the \"Stock Split\").  The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split."}],"balance_after":0,"derivative":{"exercise_price":63.95,"expiration_date":"2025-05-05","underlying":"Common Stock","underlying_shares":3722},"source":{"system":"sec-edgar","filing":"0001567619-20-015869","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920015869/doc1.xml","form_type":"4"}},{"id":3050379,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-21T21:00:22.000Z","date":"2020-08-20","kind":"sale","acquired":false,"shares":3722,"price":382.607,"value":1424063.254,"ownership":{"direct":true},"balance_after":2847,"source":{"system":"sec-edgar","filing":"0001567619-20-015869","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920015869/doc1.xml","form_type":"4"}},{"id":3050378,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-21T21:00:22.000Z","date":"2020-08-20","kind":"exercise","acquired":true,"shares":3722,"price":63.95,"value":238021.9,"ownership":{"direct":true},"balance_after":6569,"source":{"system":"sec-edgar","filing":"0001567619-20-015869","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920015869/doc1.xml","form_type":"4"}},{"id":3071815,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-03T21:03:24.000Z","date":"2020-07-30","kind":"grant","acquired":true,"shares":13,"price":371.1,"value":4824.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($4,959.24) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2847,"source":{"system":"sec-edgar","filing":"0001567619-20-014062","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920014062/doc1.xml","form_type":"4"}},{"id":3134166,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-27T20:33:23.000Z","date":"2020-05-22","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 22, 2021, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":21000,"derivative":{"exercise_price":3,"expiration_date":"2030-05-21","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-20-032315","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094159/000120919120032315/doc4.xml","form_type":"4"}},{"id":3141600,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2020-05-20T21:01:01.000Z","date":"2020-05-19","kind":"exercise","acquired":false,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 3,861 shares on May 6, 2016, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the \"Stock Split\").  The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split."}],"balance_after":3422,"derivative":{"exercise_price":63.95,"expiration_date":"2025-05-05","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001567619-20-010833","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920010833/doc1.xml","form_type":"4"}},{"id":3141599,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:01:01.000Z","date":"2020-05-19","kind":"sale","acquired":true,"shares":4000,"price":295.6082,"value":1182432.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average price of the shares sold ranging from a low of $295.68 to a high of $295.735 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":2834,"source":{"system":"sec-edgar","filing":"0001567619-20-010833","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920010833/doc1.xml","form_type":"4"}},{"id":3141598,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:01:01.000Z","date":"2020-05-19","kind":"exercise","acquired":true,"shares":4000,"price":63.95,"value":255800.0,"ownership":{"direct":true},"balance_after":6834,"source":{"system":"sec-edgar","filing":"0001567619-20-010833","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920010833/doc1.xml","form_type":"4"}},{"id":3157151,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2020-05-08T21:02:31.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":1279,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event is earlier."}],"balance_after":1279,"derivative":{"exercise_price":283.59,"expiration_date":"2030-05-05","underlying":"Common Stock","underlying_shares":1279},"source":{"system":"sec-edgar","filing":"0001567619-20-009376","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920009376/doc1.xml","form_type":"4"}},{"id":3157150,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2020-05-08T21:02:31.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":370,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."}],"balance_after":3163,"derivative":{"underlying":"Common Stock","underlying_shares":370},"source":{"system":"sec-edgar","filing":"0001567619-20-009376","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920009376/doc1.xml","form_type":"4"}},{"id":3218610,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-10T22:12:56.000Z","date":"2020-03-09","kind":"purchase","acquired":true,"shares":20000,"price":3.4,"value":68000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased the securities on the open market at purchase prices ranging from $3.40 to $3.41 per share, with a weighted average purchase price of $3.40 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":38000,"source":{"system":"sec-edgar","filing":"0001209191-20-017836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094159/000120919120017836/doc4.xml","form_type":"4"}},{"id":3295531,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-03T22:04:47.000Z","date":"2020-01-30","kind":"grant","acquired":true,"shares":22,"price":283.73,"value":6242.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($6,250.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2834,"source":{"system":"sec-edgar","filing":"0001567619-20-001949","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920001949/doc1.xml","form_type":"4"}},{"id":3384847,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-31T23:00:06.000Z","date":"2019-10-30","kind":"grant","acquired":true,"shares":23,"price":273.85,"value":6298.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($6,250.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2812,"source":{"system":"sec-edgar","filing":"0001567619-19-020253","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761919020253/doc1.xml","form_type":"4"}},{"id":3437876,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-15T20:03:56.000Z","date":"2019-08-13","kind":"purchase","acquired":true,"shares":10000,"price":3.18,"value":31800.0,"ownership":{"direct":true},"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001209191-19-046095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094159/000120919119046095/doc4.xml","form_type":"4"}},{"id":3451402,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-01T21:04:15.000Z","date":"2019-07-30","kind":"grant","acquired":true,"shares":22,"price":286.05,"value":6293.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($6,250.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2789,"source":{"system":"sec-edgar","filing":"0001567619-19-015622","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761919015622/doc1.xml","form_type":"4"}},{"id":3517237,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-21T20:10:05.000Z","date":"2019-05-17","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 17, 2020, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":21000,"derivative":{"exercise_price":12.39,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-19-031725","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094159/000120919119031725/doc4.xml","form_type":"4"}},{"id":3532396,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2019-05-10T21:21:21.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":1404,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2020 annual meeting of shareholders, whichever event is earlier."}],"balance_after":1404,"derivative":{"exercise_price":245.79,"expiration_date":"2029-05-07","underlying":"Common Stock","underlying_shares":1404},"source":{"system":"sec-edgar","filing":"0001567619-19-010453","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761919010453/doc1.xml","form_type":"4"}},{"id":3532395,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2019-05-10T21:21:21.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":427,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2020 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2020 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2020 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."}],"balance_after":2793,"derivative":{"underlying":"Common Stock","underlying_shares":427},"source":{"system":"sec-edgar","filing":"0001567619-19-010453","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761919010453/doc1.xml","form_type":"4"}},{"id":3543159,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-02T22:04:55.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":26,"price":232,"value":6032.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($5,937.50) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2767,"source":{"system":"sec-edgar","filing":"0001567619-19-009681","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761919009681/doc1.xml","form_type":"4"}},{"id":3680367,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-01T22:01:22.000Z","date":"2019-01-30","kind":"grant","acquired":true,"shares":29,"price":207.68,"value":6022.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($5,937.50) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2741,"source":{"system":"sec-edgar","filing":"0001567619-19-002177","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761919002177/doc1.xml","form_type":"4"}},{"id":3778595,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-01T21:04:16.000Z","date":"2018-10-30","kind":"grant","acquired":true,"shares":28,"price":210.22,"value":5886.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($5,937.50) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2712,"source":{"system":"sec-edgar","filing":"0001567619-18-004941","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761918004941/doc1.xml","form_type":"4"}},{"id":3857217,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-01T22:02:35.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":25,"price":237.76,"value":5944.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($5,937.50) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2684,"source":{"system":"sec-edgar","filing":"0001140361-18-034854","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036118034854/doc1.xml","form_type":"4"}},{"id":3924477,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-21T20:20:49.000Z","date":"2018-05-18","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 18, 2019, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":11000,"derivative":{"exercise_price":18.41,"expiration_date":"2028-05-17","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-18-031836","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094159/000120919118031836/doc4.xml","form_type":"4"}},{"id":3937908,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2018-05-11T23:02:29.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":2187,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2019 annual meeting of shareholders, whichever event is earlier."}],"balance_after":2187,"derivative":{"exercise_price":206.62,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":2187},"source":{"system":"sec-edgar","filing":"0001140361-18-023101","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036118023101/doc1.xml","form_type":"4"}},{"id":3937907,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2018-05-11T23:02:29.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":224,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2019 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2019 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2019 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."}],"balance_after":2366,"derivative":{"underlying":"Common Stock","underlying_shares":224},"source":{"system":"sec-edgar","filing":"0001140361-18-023101","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036118023101/doc1.xml","form_type":"4"}},{"id":3950416,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-02T21:31:22.000Z","date":"2018-04-30","kind":"grant","acquired":true,"shares":31,"price":194.49,"value":6029.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($5,937.50) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":2659,"source":{"system":"sec-edgar","filing":"0001140361-18-021319","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036118021319/doc1.xml","form_type":"4"}},{"id":3993754,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-16T17:12:46.000Z","date":"2018-03-16","kind":"exercise","acquired":false,"shares":25000,"price":4.29,"value":107250.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable in four equal installments over four years starting on the first year anniversary of the grant."}],"balance_after":113518,"derivative":{"exercise_price":4.29,"exercise_date":"2010-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-18-004490","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911018004490/edgar.xml","form_type":"4"}},{"id":3993753,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-16T17:12:46.000Z","date":"2018-03-16","kind":"sale","acquired":false,"shares":25000,"price":12.0162,"value":300405.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price of shares sold."}],"balance_after":184987,"source":{"system":"sec-edgar","filing":"0001179110-18-004490","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911018004490/edgar.xml","form_type":"4"}},{"id":3993752,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-16T17:12:46.000Z","date":"2018-03-16","kind":"exercise","acquired":true,"shares":25000,"price":4.29,"value":107250.0,"ownership":{"direct":true},"balance_after":209987,"source":{"system":"sec-edgar","filing":"0001179110-18-004490","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911018004490/edgar.xml","form_type":"4"}},{"id":4022116,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2018-03-02T22:01:31.000Z","date":"2018-02-28","kind":"exercise","acquired":false,"shares":2974,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 2,987 shares on May 7, 2015, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the \"Stock Split\").  The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split."}],"balance_after":0,"derivative":{"exercise_price":64.69,"expiration_date":"2024-05-06","underlying":"Common Stock","underlying_shares":2974},"source":{"system":"sec-edgar","filing":"0001140361-18-011687","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036118011687/doc1.xml","form_type":"4"}},{"id":4022115,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-02T22:01:31.000Z","date":"2018-02-28","kind":"sale","acquired":false,"shares":2974,"price":190.0577,"value":565231.5998,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sales price of the shares sold ranging from a low of $190.00 to a high of $190.16 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":2628,"source":{"system":"sec-edgar","filing":"0001140361-18-011687","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036118011687/doc1.xml","form_type":"4"}},{"id":4022114,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-02T22:01:31.000Z","date":"2018-02-28","kind":"exercise","acquired":true,"shares":2974,"price":64.69,"value":192388.06,"ownership":{"direct":true},"balance_after":5602,"source":{"system":"sec-edgar","filing":"0001140361-18-011687","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036118011687/doc1.xml","form_type":"4"}},{"id":4038194,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-23T10:29:30.000Z","date":"2018-02-21","kind":"sale","acquired":false,"shares":11713,"price":12,"value":140556.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price of shares sold."}],"balance_after":184987,"source":{"system":"sec-edgar","filing":"0001179110-18-002663","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911018002663/edgar.xml","form_type":"4"}},{"id":4045579,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-21T08:47:14.000Z","date":"2018-02-20","kind":"sale","acquired":false,"shares":25000,"price":11.68,"value":292000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price of shares sold."}],"balance_after":196700,"source":{"system":"sec-edgar","filing":"0001179110-18-002457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911018002457/edgar.xml","form_type":"4"}},{"id":4049533,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-02-20T10:59:07.000Z","date":"2018-02-16","kind":"exercise","acquired":false,"shares":25000,"price":4.29,"value":107250.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable as to 50,000 shares commencing on January 1, 2010, 44,639 shares commencing on January 1, 2011, 26,690 shares commencing on January 1, 2012, and 26,690 shares commencing on January 1, 2013."}],"balance_after":163518,"derivative":{"exercise_price":4.29,"exercise_date":"2010-01-01","expiration_date":"2029-01-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-18-002352","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911018002352/edgar.xml","form_type":"4"}},{"id":4049532,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-20T10:59:07.000Z","date":"2018-02-13","kind":"exercise","acquired":true,"shares":25000,"price":4.29,"value":107250.0,"ownership":{"direct":true},"balance_after":221700,"source":{"system":"sec-edgar","filing":"0001179110-18-002352","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911018002352/edgar.xml","form_type":"4"}},{"id":4060843,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-02-14T10:39:09.000Z","date":"2018-02-13","kind":"exercise","acquired":false,"shares":46667,"price":3.3,"value":154001.1,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable as to 23,334 shares commencing on June 11, 2009 and 23,333 shares commencing on June 11, 2010."}],"balance_after":0,"derivative":{"exercise_price":3.3,"exercise_date":"2009-06-11","expiration_date":"2018-06-11","underlying":"Common Stock","underlying_shares":46667},"source":{"system":"sec-edgar","filing":"0001179110-18-002037","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911018002037/edgar.xml","form_type":"4"}},{"id":4060842,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-14T10:39:09.000Z","date":"2018-02-13","kind":"sale","acquired":false,"shares":46667,"price":10.0125,"value":467253.3375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Weighted average price of shares sold."}],"balance_after":196700,"source":{"system":"sec-edgar","filing":"0001179110-18-002037","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911018002037/edgar.xml","form_type":"4"}},{"id":4060841,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47459,"kind":"person","name":"JUNIUS DANIEL M","position":1,"cik":"0001094159","reported_name":"JUNIUS DANIEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-14T10:39:09.000Z","date":"2018-02-13","kind":"exercise","acquired":true,"shares":46667,"price":3.3,"value":154001.1,"ownership":{"direct":true},"balance_after":243367,"source":{"system":"sec-edgar","filing":"0001179110-18-002037","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911018002037/edgar.xml","form_type":"4"}}],"next_cursor":"2018-02-14T10:39:09.000000Z,4060841"}